These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6136793

  • 1. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.
    Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC.
    Lancet; 1983 Sep 17; 2(8351):639-42. PubMed ID: 6136793
    [Abstract] [Full Text] [Related]

  • 2. Randomised controlled trial of the treatment of hyperlipidaemia on progression of atherosclerosis.
    Lewis B.
    Acta Med Scand Suppl; 1985 Sep 17; 701():53-7. PubMed ID: 3907295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
    Nikkilä EA, Viikinkoski P, Valle M, Frick MH.
    Br Med J (Clin Res Ed); 1984 Jul 28; 289(6439):220-3. PubMed ID: 6430414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study.
    Olsson AG, Ruhn G, Erikson U.
    J Intern Med; 1990 Jun 28; 227(6):381-90. PubMed ID: 2351925
    [Abstract] [Full Text] [Related]

  • 7. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972 Jun 28; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 8. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H, Moore RB, Matts JP, Long JM, Varco RL, Campbell GS, Pearce MB, Yellin AE, Blankenhorn DH, Holmes WL, Smink RD, Sawin HS.
    Surgery; 1982 Oct 28; 92(4):654-62. PubMed ID: 6750834
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, Mann JI, Swan AV.
    Lancet; 1992 Mar 07; 339(8793):563-9. PubMed ID: 1347091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L.
    Acta Radiol Suppl; 1994 Mar 07; 392():1-27. PubMed ID: 8184697
    [Abstract] [Full Text] [Related]

  • 18. Improvement in arterial stiffness during hypolipidaemic therapy is offset by weight gain.
    Matthews PG, Wahlqvist ML, Marks SJ, Myers KA, Hodgson JM.
    Int J Obes Relat Metab Disord; 1993 Oct 07; 17(10):579-83. PubMed ID: 8242126
    [Abstract] [Full Text] [Related]

  • 19. Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
    Hedstrand H.
    Ups J Med Sci; 1976 Oct 07; 81(2):85-92. PubMed ID: 183322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.